Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-18

FDA Approved: VALGANCICLOVIR — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals’ original application for valganciclovir, enabling a generic version of the antiviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir (Valganciclovir)

Snippet

ORIG AP for VALGANCICLOVIR (VALGANCICLOVIR)